Journal of Diabetes Investigation | |
Cancer biology in diabetes | |
Shi Sen2  Yanzheng He1  Daisuke Koya2  | |
[1] The Department of Vascular and Thyroid Surgery, The Affiliated Hospital of Luzhou Medical College, Luzhou, China;Division of Diabetes & Endocrinology, Kanazawa Medical University, Ishikawa, Japan | |
关键词: Antidiabetic drugs; Cancer; Diabetes; | |
DOI : 10.1111/jdi.12208 | |
来源: Wiley | |
【 摘 要 】
Diabetes is a serious metabolic disease that causes multiple organ dysfunctions. Recent evidence suggests that diabetes could contribute to the initiation and progression of certain cancers in addition to the classic diabetic complications. Furthermore, some of the drugs used clinically to treat patients with diabetes might affect cancer initiation, progression and mortality. The recent discovery of the possible anticancer effects of metformin, a classic antidiabetic drug, has led physicians and scientists to reconsider the interaction between diabetes and cancer. In the present review, we analyze recent reports in this field, and explore possible mechanistic links between diabetes and cancer biology.Abstract
【 授权许可】
CC BY-NC-ND
© 2014 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd
Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202107150014094ZK.pdf | 424KB | download |